KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 12 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,745 | 0.0% | 38,000 | 0.0% | 0.00% | – |
| Q2 2023 | $25,745 | -11.2% | 38,000 | 0.0% | 0.00% | – |
| Q1 2023 | $29,000 | -95.6% | 38,000 | -95.8% | 0.00% | – |
| Q2 2022 | $655,000 | -77.5% | 900,000 | -74.6% | 0.00% | – |
| Q1 2022 | $2,912,000 | -32.1% | 3,540,000 | -33.1% | 0.00% | – |
| Q4 2021 | $4,289,000 | +73.8% | 5,290,000 | +60.8% | 0.00% | – |
| Q3 2021 | $2,468,000 | -18.1% | 3,290,000 | +10.0% | 0.00% | – |
| Q2 2021 | $3,012,000 | -9.0% | 2,990,000 | 0.0% | 0.00% | – |
| Q1 2021 | $3,311,000 | -14.2% | 2,990,000 | +1.0% | 0.00% | -100.0% |
| Q4 2020 | $3,860,000 | -44.2% | 2,960,000 | -45.8% | 0.00% | 0.0% |
| Q3 2020 | $6,919,000 | +158.1% | 5,460,000 | +198.0% | 0.00% | – |
| Q4 2019 | $2,681,000 | – | 1,832,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 8,000,000 | $5,215,000 | 9.09% |
| BRAIDWELL LP | 65,976,000 | $40,943,996 | 1.29% |
| Context Capital Management, LLC | 21,494 | $13,329 | 1.07% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 30,500,000 | $20,663,750 | 0.86% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 25,000,000 | $15,264,731 | 0.24% |
| DeepCurrents Investment Group LLC | 4,250,000 | $2,700,994 | 0.12% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,500,000 | $4,654,419 | 0.02% |
| Verition Fund Management LLC | 1,359 | $843,381 | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 6,500,000 | $4,033 | 0.01% |
| BLB&B Advisors, LLC | 75,000 | $45,794 | 0.00% |